[go: up one dir, main page]

PE20081831A1 - Derivados de heteroaril-pirrolidinil- y -piperidinil-cetona - Google Patents

Derivados de heteroaril-pirrolidinil- y -piperidinil-cetona

Info

Publication number
PE20081831A1
PE20081831A1 PE2007001801A PE2007001801A PE20081831A1 PE 20081831 A1 PE20081831 A1 PE 20081831A1 PE 2007001801 A PE2007001801 A PE 2007001801A PE 2007001801 A PE2007001801 A PE 2007001801A PE 20081831 A1 PE20081831 A1 PE 20081831A1
Authority
PE
Peru
Prior art keywords
ketone
derivatives
alkyl
pyrrolidinil
piperidinil
Prior art date
Application number
PE2007001801A
Other languages
English (en)
Inventor
Pravin Iyer
Clara Jeou
Stephen M Lynch
Ann Marie Madera
Kerem Erol Ozboya
Robert James Weikert
Matthew C Lucas
Ryan Craig Schoenfeld
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39262542&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20081831(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of PE20081831A1 publication Critical patent/PE20081831A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/30—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrrole Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Seasonings (AREA)

Abstract

SE REFIERE A DERIVADOS DE HETEROARIL-PIRROLIDINIL- Y -PIPERIDINIL-CETONA DE FORMULA (I), EN DONDE m ES DE 0 A 3; n ES DE 0 A 3; Ar ES INDOLILO, INDAZOLILO, ENTRE OTROS, OPCIONALMENTE SUSTITUIDOS; R1 ES ALQUILO(C1-C6), ALQUENILO(C2-C6), ENTRE OTROS; R2 ES H O ALQUILO(C1-C6); Ra Y Rb SON INDEPENDIENTEMENTE H, ALQUILO(C1-C6), HALOGENO, ENTRE OTROS. SON SELECCIONADOS: (3-BENCIL-PIRROLIDIN-3-IL)-(1H-INDOL-5-IL)-METANONA, [3-(3-FLUOR-BENCIL)-PIRROLIDIN-3-IL]-(1H-INDOL-5-IL)-METANONA, ENTRE OTROS. TAMBIEN SE REFIERE A UNA COMPOSICION FARMACEUTICA Y UN PROCEDIMIENTO DE PREPARACION. DICHOS COMPUESTOS SON INHIBIDORES DE LA DE REABSORCION DE MONOAMINAS TALES COMO SEROTONINA, NOREPINEFRINA Y DOPAMINA; SIENDO UTILES EN EL TRATAMIENTO DE TRASTORNOS DEPRESIVOS, ANSIOLITICOS, DOLORES Y DE OTROS TIPOS
PE2007001801A 2006-12-19 2007-12-14 Derivados de heteroaril-pirrolidinil- y -piperidinil-cetona PE20081831A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US87596906P 2006-12-19 2006-12-19
US99956107P 2007-10-19 2007-10-19

Publications (1)

Publication Number Publication Date
PE20081831A1 true PE20081831A1 (es) 2008-12-27

Family

ID=39262542

Family Applications (2)

Application Number Title Priority Date Filing Date
PE2007001801A PE20081831A1 (es) 2006-12-19 2007-12-14 Derivados de heteroaril-pirrolidinil- y -piperidinil-cetona
PE2012000299A PE20121151A1 (es) 2006-12-19 2007-12-14 Derivados de heteroaril-pirrolidinil-y-piperidinil-cetona

Family Applications After (1)

Application Number Title Priority Date Filing Date
PE2012000299A PE20121151A1 (es) 2006-12-19 2007-12-14 Derivados de heteroaril-pirrolidinil-y-piperidinil-cetona

Country Status (30)

Country Link
US (2) US8084623B2 (es)
EP (3) EP2684871B1 (es)
JP (1) JP5394252B2 (es)
KR (1) KR101054189B1 (es)
CN (1) CN101563319B (es)
AR (1) AR064397A1 (es)
AT (1) ATE513808T1 (es)
BR (1) BRPI0720742B8 (es)
CA (1) CA2671378C (es)
CL (1) CL2007003672A1 (es)
CO (1) CO6190531A2 (es)
CR (1) CR10809A (es)
CY (1) CY1113916T1 (es)
DK (1) DK2354124T3 (es)
EC (1) ECSP099442A (es)
ES (2) ES2366980T3 (es)
HR (1) HRP20130362T1 (es)
IL (1) IL198879A0 (es)
MA (1) MA31142B1 (es)
MX (1) MX2009006334A (es)
MY (1) MY186650A (es)
NO (1) NO20092058L (es)
NZ (1) NZ577114A (es)
PE (2) PE20081831A1 (es)
PL (1) PL2354124T3 (es)
PT (1) PT2354124E (es)
RU (1) RU2479575C2 (es)
SG (1) SG170054A1 (es)
TW (1) TWI377202B (es)
WO (1) WO2008074703A1 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2718736A1 (en) * 2008-03-20 2009-09-24 F. Hoffmann-La Roche Ag Pyrrolidinyl derivatives and uses thereof
KR20110010783A (ko) * 2008-06-18 2011-02-07 에프. 호프만-라 로슈 아게 Ｍｒｉ로서의 아릴 케톤
ES2553612T3 (es) * 2009-02-09 2015-12-10 Sunovion Pharmaceuticals Inc. Inhibidores de la recaptación triple de pirrolidina
JP5992192B2 (ja) * 2012-03-30 2016-09-14 三井金属鉱業株式会社 パラジウム触媒
KR20150013137A (ko) 2012-04-25 2015-02-04 에프. 호프만-라 로슈 아게 (3,4-다이클로로-페닐)-((s)-3-프로필-피롤리딘-3-일)-메탄온 하이드로클로라이드 및 제조 방법
CN105102448B (zh) 2013-02-28 2018-03-06 百时美施贵宝公司 作为rock1和rock2抑制剂的苯基吡唑衍生物
TW201444798A (zh) 2013-02-28 2014-12-01 必治妥美雅史谷比公司 作爲強效ｒｏｃｋ１及ｒｏｃｋ２抑制劑之苯基吡唑衍生物
CN110642880B (zh) * 2019-10-11 2021-12-31 长沙麓兴生物科技有限公司 一种氮未取代吡唑和吲唑类硼酸的制备方法
CN114014792B (zh) * 2021-12-15 2024-01-26 沈阳海诺威医药科技有限公司 一种7-(4-溴苯甲酰基)-1,3-二氢-2h-吲哚-2-酮的制备方法
MX2024010480A (es) 2022-02-28 2024-09-05 Noema Pharma Ag Uso de inhibidor de captacion triple para el tratamiento de la depresion atipica.
CN116751157B (zh) * 2023-06-21 2025-09-12 上海再启生物技术有限公司 一种2-(2-氨基-5-溴-苯甲酰基)吡啶的放大制备方法
WO2025045932A1 (en) 2023-08-28 2025-03-06 Noema Pharma Ag A triple reuptake inhibitor for use in methods of treating a behavioral immuno-metabolic cluster condition or disorder
TW202515540A (zh) * 2023-08-30 2025-04-16 瑞士商諾埃瑪製藥公司 使用三重再攝取抑制劑治療睡眠障礙之方法
WO2025106383A1 (en) * 2023-11-17 2025-05-22 Merck Sharp & Dohme Llc Pyrrolidinyl derivatives useful as hcn1/hcn 2 modulators
WO2025146469A1 (en) * 2024-01-05 2025-07-10 Noema Pharma Ag Treatment for the symptoms of menopause and perimenopause

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3073829A (en) * 1963-01-15 Certificate of correction
US2248018A (en) * 1939-03-30 1941-07-01 Winthrop Chem Co Inc 4-aryl-piperidine-ketones and a process of preparing them
US3056795A (en) * 1958-04-30 1962-10-02 Sterling Drug Inc 3-aryl-3-(aroyl or alkanoyl)tropanes and preparation thereof
NL130088C (es) 1960-03-14
US4341698A (en) 1979-06-21 1982-07-27 Richardson-Merrell Inc. Enkaphalin derivatives
GB2060937A (en) 1979-10-12 1981-05-07 Rolls Royce Fluid-flow restrictor assembly
ZA806501B (en) 1979-10-27 1981-10-28 Richardson Merrell Inc 4-(4-alkyl-aroyl-1-piperidino)butyrophenone antipsychotic agents
US4443451A (en) 1981-07-15 1984-04-17 Janssen Pharmaceutica N.V. Bicyclic pyrimidin-5-one derivatives
CA1228867A (en) 1984-05-03 1987-11-03 Celanese Corporation Methanol carbonylation process
JPH05503517A (ja) 1989-12-18 1993-06-10 バージニア・コモンウェルス・ユニバーシティ シグマレセプターリガンド及びその用途
IL117149A0 (en) 1995-02-23 1996-06-18 Schering Corp Muscarinic antagonists
FR2735127B1 (fr) 1995-06-09 1997-08-22 Pf Medicament Nouvelles piperazines heteroaromatiques utiles comme medicaments.
GB9523583D0 (en) * 1995-11-17 1996-01-17 Merck Sharp & Dohme Therapeutic agents
FR2758327B1 (fr) 1997-01-15 1999-04-02 Pf Medicament Nouvelles arylpiperazines derivees de piperidine
US6281243B1 (en) * 1998-02-26 2001-08-28 Akzo Nobel N.V. Derivatives of azetidine and pyrrolidine
WO2001014331A2 (en) 1999-08-24 2001-03-01 Regents Of The University Of California Non-quinoline inhibitors of malaria parasites
US20020151712A1 (en) 1999-09-14 2002-10-17 Nan-Horng Lin 3-pyrrolidinyloxy-3'-pyridyl ether compounds useful for controlling chemical synaptic transmission
WO2001021577A2 (en) 1999-09-20 2001-03-29 Takeda Chemical Industries, Ltd. Melanin concentrating hormone antagonist
CA2389049A1 (en) * 1999-09-27 2001-04-05 Georgetown University Dopamine transporter inhibitors and their use
JP2004509103A (ja) 2000-09-11 2004-03-25 セプレイコー　インコーポレイテッド モノアミン受容体及び輸送体のリガンドならびにその使用方法
AU2002336273A1 (en) 2001-03-09 2002-09-24 Ortho-Mcneil Pharmaceutical, Inc. Heterocyclic compounds and their use as histamine h4 ligands.
US6569887B2 (en) * 2001-08-24 2003-05-27 Dov Pharmaceuticals Inc. (−)-1-(3,4-Dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake
US20030236277A1 (en) 2002-02-14 2003-12-25 Kadow John F. Indole, azaindole and related heterocyclic pyrrolidine derivatives
TW200403058A (en) 2002-04-19 2004-03-01 Bristol Myers Squibb Co Heterocyclo inhibitors of potassium channel function
US20040034019A1 (en) * 2002-08-08 2004-02-19 Ronald Tomlinson Piperazine and piperidine derivatives
AU2003268464A1 (en) 2002-09-03 2004-03-29 Scios Inc. INDOLE-TYPE DERIVATIVES AS INHIBITORS OF p38 KINASE
JP2006505531A (ja) * 2002-09-11 2006-02-16 メルク　エンド　カムパニー　インコーポレーテッド メラノコルチン−４受容体作働薬としてのピペラジン尿素誘導体
CA2501611A1 (en) 2002-10-11 2004-04-22 Astrazeneca Ab 1,4-disubstituted piperidine derivatives and their use as 11-betahsd1 inhibitors
WO2004080925A2 (en) 2003-03-12 2004-09-23 The University Of Western Ontario Synthesis of tetrahydro-1,2-oxazines by the cycloaddition of nitrones with cyclopropanes
US20060014987A1 (en) 2003-07-07 2006-01-19 Lan Huang Synthesis of beta-elemene, intermediates thereto, analogues and uses thereof
JP2005057154A (ja) * 2003-08-07 2005-03-03 Canon Inc 露光装置
BRPI0415767A (pt) 2003-10-24 2006-12-26 Hoffmann La Roche antagonistas de receptor de ccr-3
GB0325745D0 (en) 2003-11-05 2003-12-10 Astrazeneca Ab Chemical compounds
WO2005047253A1 (en) * 2003-11-12 2005-05-26 Lg Life Sciences Ltd. Melanocortin receptor agonists
JP4866723B2 (ja) 2004-02-26 2012-02-01 協和発酵キリン株式会社 好中球性炎症疾患の予防及び／または治療剤
WO2005123716A1 (en) 2004-06-21 2005-12-29 F. Hoffmann-La Roche Ag Indole derivatives as histamine receptor antagonists
WO2006003147A1 (en) 2004-06-30 2006-01-12 Janssen Pharmaceutica N.V. Phthalazine derivatives as parp inhibitors
TW200626155A (en) 2004-09-20 2006-08-01 Xenon Pharmaceuticals Inc Heterocyclic derivatives and their use as therapeutic agents
US20060167044A1 (en) * 2004-12-20 2006-07-27 Arnaiz Damian O Piperidine derivatives and their use as anti-inflammatory agents
DE102004061934A1 (de) 2004-12-22 2006-07-13 Siemens Ag Verfahren zur Datenübertragung zwischen einer sendenden und einer empfangenden Einheit in einem Bluetooth-Funkkommunikationssystem
MX2007008279A (es) 2005-01-25 2008-02-15 Epix Delaware Inc Compuestos de arilamina sustituidos y su uso como moduladores de la 5-ht6.
WO2006086609A2 (en) 2005-02-10 2006-08-17 Axys Pharmaceuticals, Inc. Inhibitors of tryptase
JP5219150B2 (ja) 2005-12-12 2013-06-26 ネルビアーノ・メデイカル・サイエンシーズ・エツセ・エルレ・エルレ キナーゼ阻害薬として活性な置換ピラゾロ［４，３−ｃ］ピリジン誘導体
JP5132673B2 (ja) 2006-04-07 2013-01-30 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ ヒスタミンｈ４受容体のモジュレーターとしてのインドールおよびベンゾイミダゾール

Also Published As

Publication number Publication date
DK2354124T3 (da) 2013-03-11
TW200838859A (en) 2008-10-01
US8513425B2 (en) 2013-08-20
JP2010513379A (ja) 2010-04-30
WO2008074703A1 (en) 2008-06-26
MY186650A (en) 2021-08-03
CL2007003672A1 (es) 2008-07-25
EP2354124B1 (en) 2013-02-13
EP2354124A2 (en) 2011-08-10
EP2684871A1 (en) 2014-01-15
MX2009006334A (es) 2009-06-23
EP2684871B1 (en) 2016-05-04
CN101563319B (zh) 2012-09-05
CA2671378C (en) 2015-10-20
US20080146607A1 (en) 2008-06-19
CY1113916T1 (el) 2016-07-27
BRPI0720742A2 (pt) 2014-01-28
TWI377202B (en) 2012-11-21
JP5394252B2 (ja) 2014-01-22
ECSP099442A (es) 2009-07-31
IL198879A0 (en) 2010-02-17
AR064397A1 (es) 2009-04-01
NZ577114A (en) 2011-12-22
CO6190531A2 (es) 2010-08-19
US20120065225A1 (en) 2012-03-15
RU2009122666A (ru) 2011-01-27
KR20090091194A (ko) 2009-08-26
ES2401129T3 (es) 2013-04-17
MA31142B1 (fr) 2010-02-01
HRP20130362T1 (en) 2013-05-31
ATE513808T1 (de) 2011-07-15
SG170054A1 (en) 2011-04-29
PL2354124T3 (pl) 2013-07-31
CA2671378A1 (en) 2008-06-26
AU2007336375A1 (en) 2008-06-26
RU2479575C2 (ru) 2013-04-20
US8084623B2 (en) 2011-12-27
EP2354124A3 (en) 2011-09-14
NO20092058L (no) 2009-09-17
KR101054189B1 (ko) 2011-08-03
BRPI0720742B8 (pt) 2021-05-25
ES2366980T3 (es) 2011-10-27
EP2102157B1 (en) 2011-06-22
PE20121151A1 (es) 2012-08-27
CN101563319A (zh) 2009-10-21
BRPI0720742B1 (pt) 2021-02-09
CR10809A (es) 2009-06-25
PT2354124E (pt) 2013-04-09
EP2102157A1 (en) 2009-09-23

Similar Documents

Publication Publication Date Title
PE20081831A1 (es) Derivados de heteroaril-pirrolidinil- y -piperidinil-cetona
PE20080997A1 (es) Compuestos n-fenilmetil-5-oxo-prolina-2-amida como moduladores de receptores p2x7
PE20060777A1 (es) Derivados de indolinona para el tratamiento o la prevencion de enfermedades fibroticas
EA200970913A1 (ru) 2-пиридинкарбоксамидные производные в качестве модуляторов натриевых каналов
PE20170666A1 (es) 2-(morfolin-4-il)-1,7-naftiridinas
PE20170247A1 (es) Derivados de pirrolidina-2,5-diona, composiciones farmaceuticas y metodos para usar como inhibidores ido1
PE20090890A1 (es) Compuestos derivados de 1-(2,3-dihidrobenzo[1,4]dioxin-2-ilmetil)azaciclos como antagonistas del suptipo adrenoreceptor alfa2c
PE20081238A1 (es) Piperidinas sustituidas como antagonistas de hdm2
EA201100161A1 (ru) Производные хинуклидина карбоната и их медицинские композиции
PE20081362A1 (es) DERIVADOS MORFOLINO PIRIMIDINA COMO INHIBIDORES DE mTOR QUINASA Y PI3K
PE20091173A1 (es) Derivados de heteroarilo como antagonistas de receptor de orexina
JO2787B1 (en) Alternative amide derivatives and methods of use
PE20120620A1 (es) Dihidropirazolonas sustituidas como inhibidores de hif-propil-4-hidroxilasas
PE20090816A1 (es) Derivados de pirrolopirimidinona como agentes ligandos de los receptores p2x3
EA200901133A1 (ru) Производные дианилинопиримидина как ингибиторы киназы wee1, фармацевтическая композиция и применение
PE20110152A1 (es) Nuevos derivados de sulfamida sustituida
PE20070833A1 (es) Compuestos de pirimidinil benzotiofeno
PE20091486A1 (es) Derivado de pirrolopirimidina como inhibidor de la enzima pi3k
EA201000280A1 (ru) Фармацевтические композиции, содержащие лиганды дофаминовых рецепторов, и способы лечения с помощью лигандов дофаминовых рецепторов
CO6270285A2 (es) Derivados de 4-[(4-amino-1, 3, 5-triazin-2-il)amino]-n-arilmetilcicloalquilcarboxamida
PE20061150A1 (es) Derivados de n-(n-sulfonilaminoarilmetil)ciclopropanocarboxamida sustituidos como antagonistas del receptor vainilloide tipo 1 (vdr1)
PE20051054A1 (es) Compuestos heterociclicos utiles como secretagogos de la hormona de crecimiento
BRPI0716069A2 (pt) composto, composiÇço farmacÊutica, e, mÉtodo para tratar um distérbio
PE20091330A1 (es) Derivados de 4-aminopirimidina como antagonistas de receptores de histamina h4
PE20081753A1 (es) Compuestos y composiciones como inhibidores de la proteasa activadora de canal

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed